SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Wanbury - Quaterly Results

20 Oct 2023 Evaluate
The revenue for the September 2023 quarter is pegged at Rs. 1444.62 millions, about 16.54% up against Rs. 1239.55 millions recorded during the year-ago period.The Total Profit for the quarter ended September 2023 of Rs. 73.62 millions grew from Rs.-8.90 millionsThe company reported a good operating profit of 181.00 millions compared to 63.77 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 1444.62 1239.55 16.54 2907.47 2408.95 20.69 4996.47 5111.86 -2.26
Other Income 7.56 7.80 -3.08 13.73 27.15 -49.43 9.13 15.08 -39.46
PBIDT 181.00 63.77 183.83 320.65 52.68 508.68 240.85 368.21 -34.59
Interest 76.71 39.35 94.94 134.60 72.44 85.81 213.94 206.11 3.80
PBDT 104.29 24.42 327.07 186.05 -19.76 -1041.55 20.97 925.78 -97.73
Depreciation 32.43 31.52 2.89 64.28 61.86 3.91 123.85 114.50 8.17
PBT 71.86 -7.10 -1112.11 121.77 -81.62 -249.19 -102.88 811.28 -112.68
TAX -1.76 1.80 -197.78 1.26 -0.27 -566.67 1.09 -3.46 -131.50
Deferred Tax -1.76 1.80 -197.78 1.26 -0.27 -566.67 1.09 -3.46 -131.50
PAT 73.62 -8.90 -927.19 120.51 -81.35 -248.14 -103.97 814.74 -112.76
Equity 327.36 326.96 0.12 327.36 326.96 0.12 327.06 326.66 0.12
PBIDTM(%) 12.53 5.14 143.54 11.03 2.19 404.32 4.82 7.20 -33.08

Wanbury Share Price

259.05 -6.90 (-2.59%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×